GlassScriptPhysician profile
Gaetano Rocco
NPI 1548756570
$13,110.16
in general payments reported to CMS, 2019-2025
5 companies · $53.38 in 2025
The $53.38 reported for 2025 was less than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
See the full distribution for Thoracic Surgery (Cardiothoracic Vascular Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,305 · 2020: $38.05 · 2021: $5,809 · 2022: $13.70 · 2023: $1,195 · 2024: $1,696 · 2025: $53.38.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $1,525 · Travel and Lodging: $841 · Food and Beverage: $578.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $1,525.00 |
| Travel and Lodging | $841.15 |
| Food and Beverage | $578.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $9,122.99 | 2019-2024 | Da Vinci Surgical System |
| Astrazeneca Uk Limited | $2,148.00 | 2021 | |
| Merck Sharp & Dohme LLC | $1,525.00 | 2024 | |
| Medtronic, INC. | $211.05 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $103.12 | 2023-2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gaetano Rocco listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.